GUTS (Fractyl Health) Interest Coverage : N/A (As of Mar. 2025)

View and export this data going back to 2024. Start your Free Trial

What is Fractyl Health Interest Coverage?

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Fractyl Health's Operating Income for the three months ended in Mar. 2025 was $-24.76 Mil. Fractyl Health's Interest Expense for the three months ended in Mar. 2025 was $0.00 Mil. GuruFocus does not calculate 's interest coverage with the available data. The higher the ratio, the stronger the company's financial strength is.

The historical rank and industry rank for Fractyl Health's Interest Coverage or its related term are showing as below:

GUTS's Interest Coverage is not ranked ^*
in the Biotechnology industry.
Industry Median: 119.89
* Ranked among companies with meaningful Interest Coverage only.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Fractyl Health Interest Coverage Historical Data

The historical data trend for Fractyl Health's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Fractyl Health Interest Coverage Chart

Fractyl Health Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Interest Coverage

Get a 7-Day Free Trial

N/A

Fractyl Health Quarterly Data
	Dec19	Sep20	Dec20	Jun21	Sep21	Dec21	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Interest Coverage	Get a 7-Day Free Trial												N/A	N/A	N/A	N/A	N/A

Competitive Comparison of Fractyl Health's Interest Coverage

For the Biotechnology subindustry, Fractyl Health's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fractyl Health's Interest Coverage Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Fractyl Health's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Fractyl Health's Interest Coverage falls into.

Save Embed

;

Save Embed

;

Fractyl Health Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage

-1

Operating Income

Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt ⁽¹⁾.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Fractyl Health's Interest Coverage for the fiscal year that ended in Dec. 2024 is calculated as

Here, for the fiscal year that ended in Dec. 2024, Fractyl Health's Interest Expense was $0.00 Mil. Its Operating Income was $-93.53 Mil. And its Long-Term Debt & Capital Lease Obligation was $57.54 Mil.

GuruFocus does not calculate Fractyl Health's interest coverage with the available data.

Fractyl Health's Interest Coverage for the quarter that ended in Mar. 2025 is calculated as

Here, for the three months ended in Mar. 2025, Fractyl Health's Interest Expense was $0.00 Mil. Its Operating Income was $-24.76 Mil. And its Long-Term Debt & Capital Lease Obligation was $56.43 Mil.

GuruFocus does not calculate Fractyl Health's interest coverage with the available data.

The higher the ratio, the stronger the company's Financial Strength is.

Fractyl Health (NAS:GUTS) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .

Fractyl Health Interest Coverage Related Terms

Thank you for viewing the detailed overview of Fractyl Health's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.

Fractyl Health Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Fractyl Health Inc (NAS:GUTS) » Definitions » Interest Coverage

Comparable Companies

Traded in Other Exchanges

N/A

Address

3 Van de Graaff Drive, Suite 200, Burlington, MA, USA, 01803

Website

https://www.fractyl.com

Fractyl Health Inc is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity. The company focuses on transforming metabolic disease treatment from chronic symptomatic management to durable disease modifying therapies that target the organ level root causes of T2D and obesity.